Mon. 13 May 2024, 4:48pm ET
Benzinga
Earnings, Earnings Misses, News
Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate of $(1.00) by 31 percent. This is a 30.69 percent increase over losses of $(1.89) per share from the same period last year.